SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506879

INE942C01045

24.267589

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUJTHEM

82.06

3925.47

EPS(TTM)

Face Value()

Div & Yield %

4.39

0.19

Back

sanwaria consumer ltd

Colinz Laboratories standalone net profit rises 60.00% in the December 2025 quarter

Jan 27,2026

Net profit of Colinz Laboratories rose 60.00% to Rs 0.08 crore in the quarter ended December 2025 as against Rs 0.05 crore during the previous quarter ended December 2024. Sales declined 2.72% to Rs 1.43 crore in the quarter ended December 2025 as against Rs 1.47 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1.43	1.47	-3
OPM %	6.29	4.08	-
PBDT	0.16	0.13	23
PBT	0.12	0.10	20
NP	0.08	0.05	60

76,664.21 -999.79 ( -1.29%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)